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ABSTRACT 
Endotoxin lipopolysaccharide (LPS) is known to cause liver injury primarily involving 
inflammatory cells such as Kupffer cells, but few in vitro culture models are applicable for 
investigation of inflammatory effects on drug metabolism. We have developed a 3D human 
microphysiological hepatocyte-Kupffer-cell coculture system and evaluated the anti-
inflammatory effect of glucocorticoids on liver cultures. LPS was introduced to the cultures 
to elicit an inflammatory response and assessed by the release of pro-inflammatory 
cytokines, IL6 and TNFα. A sensitive and specific RP-UHPLC-QTOF-MS method was 
used to evaluate hydrocortisone disappearance and metabolism at near physiological levels. 
For this, the systems were dosed with 100 nM hydrocortisone and circulated for two days; 
hydrocortisone was depleted to approximately 30 nM, with first-order kinetics. Phase I 
metabolites, including tetrahydrocortisone and dihydrocortisol, accounted for 8-10 % of the 
loss, and 45-52 % was phase II metabolites, including glucuronides of tetrahydrocortisol and 
tetrahydrocortisone.  Pharmacokinetic parameters, i.e., half-life (t1/2), rate of elimination 
(kel), clearance (CL), and area under the curve (AUC), were 23.03 h, 0.03 h-1, 6.6x10-5 L. h-1 
and 1.03  

  h respectively.  The ability of the bioreactor to predict the in vivo clearance of 
hydrocortisone was characterized and the obtained intrinsic clearance values correlated with 
human data. This system offers a physiologically-relevant tool for investigating hepatic 
function in an inflamed liver.   
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INTRODUCTION 
Inflammation of the liver may result from infection, autoimmune disorders, alcohol 
abuse or fat accumulation (Adams et al., 2010).  Severe inflammation can be life-threatening 
while mild inflammation can change drug metabolism profiles (Adams et al., 2010) and may 
play a role in liver injury (Park et al., 2004; Deng et al., 2009).  Drug induced liver injury 
has resulted in late-stage clinical trial failures and post-market withdrawals (Guengerich, 
2011).  
A postulated mechanism for toxicity involves leakage of bacterial products from the 
gut to the liver, causing inflammation-related susceptibility to liver injury (Deng et al., 
2008). This has been demonstrated in animal models (Roth et al., 2003; Deng et al., 2009; 
Roth and Ganey, 2010) but could be supported by a human-derived in vitro model that 
recapitulates the response of liver to inflammation. The simplest model is the 2D culture of 
primary hepatocytes, either as a monolayer or overlaid with extracellular matrix components 
in multiwall plates. Through exogenous addition of cytokines or other inflammatory stimuli 
to the cultures, 2D hepatocyte monocultures can probe inflammation-associated drug 
hepatotoxicity (Cosgrove et al., 2009). The absence of macrophages, however, makes it 
unsuitable for modelling anti-inflammatory effects.  
Numerous advanced liver models, which improve the long term functional 
performance of hepatocytes compared to monocultures, have been described (Groothuis and 
Meijer, 1992; LeCluyse et al., 2012); a sub-set of these, incorporates liver non-parenchymal 
cells in coculture (Maier and Milosevic, 1999; Milosevic et al., 1999; Zinchenko et al., 
2006; Dash et al., 2009a; Domansky et al., 2009; Kostadinova et al., 2013). For 
inflammatory models, cultures containing Kupffer cells - either added as a separate fraction 
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or as part of a whole non-parenchymal fraction - are most relevant.  In these systems the 
non-parenchymal cell fraction or Kupffer cells may be mixed with hepatocytes to form 
heterogeneous aggregates (Drewitz et al., 2011; Messner et al., 2013; Thoma et al., 2014), 
supported on a scaffold (Dash et al., 2009b; Kostadinova et al., 2013) or separated through 
micropatterning (Zinchenko et al., 2006). Transwell devices have also been evaluated 
(Milosevic et al., 1999).  Hoebe, et al., (Hoebe et al., 2000; Hoebe et al., 2001) showed that 
direct cell-to-cell contact between porcine hepatocytes and Kupffer cells increased the 
inhibitory effects of LPS stimulation on testosterone metabolism.  Hepatocyte and Kupffer 
cell models have also been applied to the study of Kupffer cell suppression of cytochrome 
P450-mediated metabolism in humans (Sunman et al., 2004) and rat cells (Milosevic et al., 
1999).  Models based on hepatocytes and a mixed non-parenchymal cell fraction system 
have also been used to explore exaggerated hepatotoxicity in conjunction with an underlying 
inflammation (Dash et al., 2009b; Drewitz et al., 2011; Messner et al., 2013; Thoma et al., 
2014), 
Cortisol and, more typically the more potent synthetic glucocorticoid 
dexamethasone, are used at nanomolar to micromolar concentrations in cultures of primary 
hepatocytes to maintain a differentiated state (Hewitt et al., 2007; Scheving et al., 2007; 
Godoy et al., 2010). In a coculture of rat hepatocytes and epithelial cells, cortisol increased 
albumin secretion and extra-cellular matrix production (Baffet et al., 1982; Guillouzo et al., 
1984).  
Cortisol, the major glucocorticoid in humans, is produced in the adrenal cortex; 
regulated both by diurnal rhythms and in response to stress (Morse and Davis, 1990).  When 
used as a drug, it is referred to as hydrocortisone, and it acts in vivo as an anti-inflammatory 
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and suppresses immune responses (Perogamvros et al., 2012).  Most serum cortisol is bound 
to proteins, including corticosteroid binding globulin (CBG) and serum albumin 
(Perogamvros et al., 2011a; Perogamvros et al., 2011b), with both free and total 
concentrations varying diurnally.  Free concentrations are between 10-300 nM (Lewis et al., 
2005; Levine et al., 2007).  Free cortisol passes easily through cellular membranes into the 
cytosol, where it can be converted to the inactive form - cortisone - or bind to intracellular 
cortisol receptors and reach the nucleus (Fig. 1). The anti-inflammatory effect and 
metabolism of cortisol on liver have not been studied extensively in vitro. 
Here we introduce a cryopreserved primary human hepatocyte and Kupffer cell 
inflammatory liver model in which the cells are cultured in direct contact on an engineered 
scaffold recapitulating the liver capillary bed under perfusion (Fig. 2) (Powers et al., 2002a; 
Domansky et al., 2010).  The model is used to examine the anti-inflammatory effect of 
glucocorticoids on liver cultures and, in conjunction with a sensitive and specific RP-
UHPLC-QTOF-MS method, to study the metabolism of hydrocortisone at near 
physiological levels. The distribution of metabolites is compared to that in human urine.  
 
MATERIALS AND METHODS 
Deuterated hydrocortisone (DLM-2218-0), used as internal standard, was from 
Cambridge Isotope Laboratories (Tewksbury, MA). HPLC grade (≥ 99.9 %) methanol 
(CAS: 67-56-1), chloroform (CAS: 67-66-3), acetonitrile (CAS: 75-05-8), formic acid, 
(CAS: 64-18-6), molecular biology grade DMSO (CAS: 67-68-5), dexamethasone (CAS: 
50-02-2), hydrocortisone (CAS: 50-23-7) and 17-α-hydroxy-3,20-dioxopregn-4-en-21-yl-β-
D-glucuronide were purchased from Sigma Aldrich (St. Louis, MO). Calibration/tuning 
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standard for the QTOF was from Agilent Technologies (Santa Clara, CA). The Oasis HLB 
cartridges were from EMD Millipore Corporation (Billerica, MA). Distilled water and 
acetonitrile were prepared in-house with double distillation.  
 
Coculture in the LiverChip  
Cryopreserved human hepatocytes and human Kupffer cells were purchased from 
Life Technologies (Paisley, UK). Cells were thawed according to the instructions provided 
by the supplier. Viability was assessed using the trypan blue exclusion test (Strober, 2001) 
and was > 85 % for all lots.  
Cells were seeded into LiverChip platforms (CNBio Innovations, UK) (Fig. 2A) 
housed in a humidified cell culture incubator at 37 °C with 5 % CO2. The LiverChip 
platforms consist of 12 fluidically isolated bioreactors in which fluid is re-circulated by a 
pneumatically driven micro-pump controlled by LiverChip hardware (Fig. 2B) through a 
scaffold containing cells (Fig. 2C). The scaffold enables the formation of an array of 3D 
microtissues composed of either hepatocytes alone or hepatocytes in coculture with non-
parenchymal cells (Kupffer cells) (Domansky et al 2010). The platform is covered with a 
single loose lid, as per a standard microtiter plate enabling access to each of the 12 
bioreactors for cell seeding, media change and sampling. Each bioreactor can hold a 
maximum of 2.5mL and has a surface channel which allows for efficient re-oxygenation of 
the media by gaseous exchange with the atmosphere.   
Cells were seeded with flow in the downward direction through the scaffold, for 8 h 
at a flow rate of 1.0 µL/s (Fig. 2D). Downward flow encourages cells to seed within the 
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scaffold and form microtissues. Following cell attachment within the scaffold, the flow was 
changed to the upward direction and maintained at 1.0 µL/s for the remainder of the culture.  
Hepatocytes monocultures were seeded at a density of 0.6 x 106 viable cells in 1.6 
mL of medium per well. The cells were maintained in Williams’ E Medium (WEM) 
containing primary hepatocyte thawing and plating supplements (Life Technologies, 
Paisley, UK) for the first 24 h of culture and in WEM containing primary hepatocyte 
maintenance supplements thereafter for the duration of the culture.  
Hepatocyte and Kupffer cell cocultures were seeded simultaneously, maintaining the 
same number of hepatocytes while adjusting the number of Kupffer cells to achieve the 
desired ratios of hepatocytes: Kupffer cells (Supplemental Table 1). Cocultures were seeded 
in WEM containing primary human hepatocyte thawing and plating supplements for the first 
24 h of culture, and then in WEM with primary human hepatocyte maintenance 
supplements. On day 3, for both mono and cocultures, where appropriate, hydrocortisone 
(100 nM) was substituted for 100 nM dexamethasone and the media was changed every 48 
h.  To induce an inflammatory state in the cultures lipopolysaccharide (LPS) (Sigma, Poole, 
UK) was added in the culture medium. 
 
Total protein  
Cells and scaffolds were washed once in phosphate buffered saline (PBS) and lysed 
using 0.5 mL of 0.1 M NaOH containing 2 % sodium dodecyl sulphate (SDS). Total cellular 
protein was then measured with a Pierce BCA Protein Assay kit (Thermo Fisher, 
Loughborough, UK).  
 
This article has not been copyedited and formatted. The final version may differ from this version.
DMD Fast Forward. Published on April 29, 2015 as DOI: 10.1124/dmd.115.063495
 at A
SPET Journals on M
ay 4, 2015
dm
d.aspetjournals.org
D
ow
nloaded from
 
DMD #63495 
 
 9
Hepatocyte and Kupffer cell phenotyping 
Albumin secretion was measured with a human albumin ELISA (Assay Pro, St 
Charles, USA). Urea was quantified with a colorimetric assay kit (BioAssay Systems, 
Hayward, USA). Interleukin 6 (IL6) and tumor necrosis factor alpha (TNFα) production 
were quantified in culture medium using human DuoSet Kits (R&D Systems, Abingdon, 
UK).  
 
CYP3A activity 
CYP3A activity was measured with the P450-Glo™ CYP3A4 assay with Luciferin-
IPA (Promega, Southampton, UK). A complete medium change to medium containing a 
1000-fold dilution of Luciferin-IPA was performed and the plate returned to the incubator, 
with flow. After 1 hour, 50 µL from each well was placed in an opaque 96 well assay plate 
and 50 µL of the luciferin detection reagent was added. The plate was incubated at room 
temperature for 20 minutes, protected from the light, and luminescence measured relative to 
a standard curve of beetle luciferin potassium salt (Promega, Southampton, UK).  
 
Metabolite extraction 
Frozen samples for an analytical series were thawed at the same time and kept on 
ice. Unused samples were then immediately stored at -80 °C. A stock solution of 1.25 µM of 
d4-hydrocortisone (d4-HC) was prepared and 2 µL were spiked into a 50 µL of sample for a 
final concentration of 50 nM. The samples were incubated in ice for 2 minutes after adding 
cold methanol and cold chloroform (HPLC grade) at a 1:1:4 ratio relative to sample volume. 
After vortexing for 20 seconds and shaking for another 5 minutes, the samples were 
This article has not been copyedited and formatted. The final version may differ from this version.
DMD Fast Forward. Published on April 29, 2015 as DOI: 10.1124/dmd.115.063495
 at A
SPET Journals on M
ay 4, 2015
dm
d.aspetjournals.org
D
ow
nloaded from
 
DMD #63495 
 
 10
incubated at -20 °C for 30 minutes. Subsequently, the samples were again vortexed for 20 
seconds followed by centrifugation at 15,000 rpm for 10 minutes. The organic phase was 
collected carefully with a special narrow gel tip (Bioscience, Inc., Salt Lake City, Utah), and 
dried in a SpeedVac®. Samples were immediately prepared for LC-MS by resuspending in 
50 µL of 2 % ACN containing 0.1 % formic acid.  
 
Preparation of standards for calibration curves 
Hydrocortisone was dried overnight under vacuum to remove any residual water. 
Distilled water was used to prepare different concentrations of HC (e.g., 2, 5, 10, 20 µM) 
and verify the accurate concentration of a working stock solution by UV absorption. The 
concentration of each HC solution was determined by UV, at 242 nm with ε =16000 as the 
molar extinction coefficient.  
LC-MS standards were prepared by diluting the working stock solution with 
Williams’ E medium to give concentrations of 5, 10, 50, 75, 100 and 200 nM. All LC-MS 
standards and stock solutions were stored at 4 °C and allowed to equilibrate at room 
temperature for at least 15 min before use. For calibration, a 50 μL aliquot of each LC-MS 
standard was spiked with 2 μL of the 1.25 µM d4-HC internal standard solution and the 
metabolites were extracted as previously described. Samples for LC-MS analyses were 
immediately resuspended in 50 µL of 2 % ACN containing 0.1 % formic acid. The 
calibration curve was constructed by plotting the peak area ratios of hydrocortisone relative 
to those of d4-HC against the concentrations (nM) of the LC/MS standards.  
 
LC-MS parameters and metabolite profiling 
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The method validations are described in the Supporting material.  LC-MS analyses 
were performed on an Agilent 6530 Accurate-Mass LC-Quadrupole-Time-of-Flight (QTOF) 
mass spectrometer with an Agilent Jet Stream electrospray ionization source and 
MassHunter workstation (v. B.06). The mass spectrometer was interfaced with an Agilent 
1290 Ultra Performance Liquid Chromatography (UPLC) system. The column was an 
Agilent Extend-C18 (2.1 × 50 mm, 1.8 μm; Agilent Technologies, Santa Clara, CA). The 
column compartment temperature was set at 40 °C. The QTOF was calibrated daily using 
the standard tuning solution from Agilent Technologies. The mass spectra were acquired in 
positive ion mode for total and free hydrocortisone measurements and in negative ion mode 
for the analysis of glucuronides. Mass spectra were collected between m/z 70 and 1000 
either at 2 scans/sec or 4 scans/sec. The ion spray voltage was set at 3800 V; the heated 
capillary temperature was 350 °C; drying gas was 8 L/min; nebulizer was 30 psi; sheath gas 
temp was set at 380 °C; sheath gas flow was 12 L/min. Two reference masses (m/z 
121.0509: C5H4N4; m/z 922.0098: C18H18O6N3P3F24) were continuously infused to allow 
mass correction during the run.  MS/MS spectra were typically obtained at collision energy 
of 20 eV.  Variations of retention times and m/z values were ≤ 0.2 min and 10 mDa, 
respectively, and the relative standard deviations (RSD) of peak areas were below 20 %, 
indicating good reproducibility and stability of the chromatographic separation and mass 
accuracy during a sequence (typically over 100 runs). The mobile phases were double-
distilled water containing 0.1 % formic acid (A) and distilled acetonitrile containing 0.1 % 
formic acid (B). A linear gradient was run from 2 % to 95 % B over 12 minutes at 0.4 
mL/min.  
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Data processing 
Hydrocortisone disappearance was followed on the QTOF in MS mode. Data were 
processed using Agilent MassHunter qualitative analysis software (v. B.06). Peak areas of 
HC (m/z 363.2171), d4-HC (m/z 367.2423) and dexamethasone (m/z 393.2077) were 
obtained using the Extracted Ion Chromatogram (EIC) function.  Hydrocortisone and 
metabolites data were analyzed both manually and using the Molecular Feature Extractor 
(MFE), i.e., all signals associated with a given analyte, with intensities > 1000, were used to 
profile metabolites, with a 10 ppm mass accuracy threshold. The data were further processed 
using Microsoft Excel 2011 and quantification was based on calibration curves built with 
known concentrations of hydrocortisone standards. GraphPad PRISM software was used to 
plot the data using the means of biological replicates with corresponding relative standard 
deviations.  
Targeted MS/MS spectra, via matched exact masses and associated retention times, 
were generated on the Agilent QTOF 6530 mass spectrometer (Santa Clara, CA) to support 
the identities of the metabolites, followed by metabolic pathway or function analysis with 
the KEGG database (http://www.genome.jp/kegg/; http://metlin.scripps.edu/index.php). The 
MS/MS spectra were also analyzed with the Agilent Molecular Structure Correlator (MSC), 
which compares the accurate mass of the MS/MS fragment ions for a compound of interest 
with one or more proposed structures for that compound. 
 
Analysis of glucuronides  
LC-MS analyses of glucuronides were also performed on the Agilent 6530 mass 
spectrometer. Conditions for calibration and sample analyses were the same as those for 
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metabolite profiling by LC-MS except that negative ion mode was used. To a 50 μL aliquot 
of the bioreactor culture medium was added 5 μL of the glucuronide-IS solution to make a 
final concentration of 50 nM 17-α-hydroxy-3,20-dioxopregn-4-en-21-yl-β-D-glucuronide 
and the mixture was then diluted with 100 μL of 5 mM ammonium acetate buffer (pH 5). 
The samples were thoroughly mixed and then applied to an Oasis HLB cartridge (10 mg, 1 
mL) after washing the cartridges with methanol (1 mL) and water (1 mL). The cartridges 
were then washed with water (1 mL) to remove unbound material and the glucuronides 
eluted with methanol (1 mL). The samples were then dried in a SpeedVac® and immediately 
resuspended in 25 µL of water with 2 % ACN and 0.1 % formic acid.   
 
Estimation of in vitro hydrocortisone pharmacokinetic parameters 
Hydrocortisone pharmacokinetics parameters were calculated using the following 
equations (Eq. 1-4) where t1/2 is the half-life, kel is the rate of elimination, CL is the 
clearance, Vd is the volume of distribution, AUC is the area under the curve, t is time and C 
is concentration. The Vd of the system was 2.2 mL. 
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Measurements of unbound (free) hydrocortisone 
A fast UPLC-MS/MS method was developed to analyze free HC without sample 
preparation. The LC parameters were the same as previously described. The switching valve 
of the Agilent 6530 Accurate-Mass LC-Quadrupole-Time-of-Flight (QTOF) mass 
spectrometer was used to divert salt content to waste from 0-2.7 min and high protein 
content from 4-13 min (the HC elutes at 3.4 min). Two different samples were analyzed: 1) 
hepatocyte and Kupffer cell cocultures at time zero containing 100 nM HC and 1.25 mg/mL 
HSA; and 2) hepatocyte and Kupffer cell cocultures at time zero containing 100 nM HC and 
25 mg/mL HSA. The injection volume was limited to 1 µL to avoid overloading the column.  
 
RESULTS 
Coculture model characterization 
Several ratios (Supplemental Table 1) of human cryopreserved hepatocytes and 
human cryopreserved Kupffer cells i.e., 15:1 (low inflammation), 10:1 (moderately 
inflamed) and 2.5:1 (highly inflamed) were cultured in the micro-bioreactor platform and 
assessed over an 8 day period The cell health and differentiated state of the primary human 
hepatocytes maintained over 8 days in the bioreactor were monitored.  Finally, LPS was 
introduced to the cultures to elicit an inflammatory response, as assessed by the release of 
pro-inflammatory cytokines, IL6 and TNFα via sandwich ELISAs.  
Phase contrast imaging (Nikon, Ti-Eclipse) was used to visualize the morphology of 
the tissue formation within the scaffold after 8 days in culture.  Figure 3 shows the tissue 
formation in mono- and 10:1 cocultures; no change in microtissue structure is observed as a 
result of the addition of Kupffer cells. CYP3A activity and total protein levels were 
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measured at day 8 (Supplemental Figure 1). No significant differences were observed 
between the four conditions, demonstrating that the addition of Kupffer cells did not 
adversely affect cell health or inhibit the CYP3A activity in LPS naïve cultures.  The 
albumin production rates after 8 days culture were greater than 30 µg/mg total protein/day 
for all conditions, a level similar to human in vivo production (Supplemental Figure 1).   
To assess the functionality of the Kupffer cells in cocultures with hepatocytes, 
cultures were exposed to LPS (1 µg/mL) for 48 h starting on day 6 (Fig. 4). TNFα was 
measured as a marker of Kupffer cell activation. In LPS naïve cultures, the TNFα 
concentration was ~19 pg/mL after 48 h period. The addition of LPS caused increased 
secretion of TNFα into the culture medium. The level of production of cytokines was 
dependent on the number of Kupffer cells seeded in the culture. The highest ratio of 
hepatocytes to Kupffer cells (2.5:1) resulted in a 42-fold increase in TNFα production, in 
comparison with 15: 1 which induced a 32-fold increase in production. Before stimulation 
the Kupffer cells were relatively quiescent but clearly remained viable and responsive to the 
addition of supra-physiological levels of LPS. IL6 production followed similar trends upon 
LPS stimulation. Stimulation of mono-cultures resulted in undetectable levels of cytokines 
in the media confirming Kupffer cells are responsible for cytokine production and the 
cryopreserved human hepatocyte lots used in this study are uncontaminated with residual 
amounts of Kupffer cells (data not shown).  
 
Anti-inflammatory capacity of coculture in response to endogenous and synthesized 
glucocorticoids 
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 Hydrocortisone, a human endogenous glucocorticoid, has anti-inflammatory 
properties.  Cocultures were exposed to various concentrations of hydrocortisone (0, 100 
and 500 nM) up to day 7 in culture. To assess the effects of these concentrations, cytokine 
production was measured after the addition of 1 µg/mL LPS for 24 h. As expected, in LPS 
naïve culture, low levels of TNFα and IL6 were detected (Supplemental Figure 2). Cultures 
without hydrocortisone produced the highest levels of cytokines with 1350 and 1043 pg for 
TNFα and IL6 respectively. The addition of 100 and 500 nM hydrocortisone caused a 
decrease in TNFα to 355 and 191 pg respectively. Similar trends were observed for IL6.   
 To determine if the model has utility as platform to screen anti-inflammatory 
compounds, the anti-inflammatory effects of hydrocortisone and dexamethasone were 
assessed at 100 nM (Supplemental Figure 3). After dosing with either hydrocortisone or 
dexamethasone from day 3 to 7, the cultures were stimulated with 1 µg/mL LPS for 24 h. 
Hydrocortisone showed a modest anti-inflammatory effect whilst dexamethasone showed a 
greater reduction in the levels of both TNFα and IL6. 
 
Experimental workflows  
Figure 5 shows the experimental workflow for the quantification of hydrocortisone 
and metabolite profiling. The protocol is described in detail in the materials and methods 
sections; briefly, samples were spiked with internal standard, extracted with methanol and 
chloroform, dried and analyzed using RP-UHPLC-QTOF-MS. The aqueous layer was 
analyzed to confirm that there was no loss of hydrocortisone during the extraction process 
(Supplemental Figure 4). For the analysis of the glucuronides (Supplemental Figure 5), the 
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samples were solid phase extracted in an Oasis HLB, then dried in a SpeedVac® and 
analyzed using RP-UHPLC-QTOF-MS. 
 
Hydrocortisone clearance 
Cocultures were seeded in LiverChip in duplicate to estimate biological variability 
within the bioreactor wells. Each well was treated with 100 nM of hydrocortisone and 
culture media samples collected at 0, 24, and 48 h were analyzed.  Variation from technical 
sources, such as pipetting and liquid extraction was assessed. Each well was extracted two 
times and each extraction was run twice consecutively in positive ion mode in RP-UHPLC-
QTOF-MS (Supplemental Figure 6). A concern in drug clearance studies in bioreactors is 
whether the drug is adsorbed onto any of the materials used in the apparatus.  Two other 
wells without cells were therefore used as controls for non-specific binding experiments, 
using the same drug dose, sample collection and analysis.  The concentration of 
hydrocortisone was virtually constant over a period of 4 h i.e., any loss of HC during 
coculture experiments can be attributed to cellular metabolism (Supplemental Figure 7).  
Hydrocortisone disappearance in the bioreactor is plotted in Fig. 6.  Under non-
inflamed conditions, 100 nM hydrocortisone was depleted to approximately 30 nM in the 
culture medium after 48 h. A logarithmic plot (ln HC/HC0) vs time post dosing 
(Supplemental Figure 8); indicates that the clearance of HC follows first order kinetics.  
 
Donor-to-donor variability 
 Hepatocytes and Kupffer cells from three different donor pairs (Supplemental Table 
2) were plated as cocultures under non-inflamed conditions and treated with 100 nM 
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hydrocortisone. The assessment was made by comparing the HC disappearance rates of each 
one of the donors (Supplemental Figure 9).  The % RSD was ≤ 15%, confirming that the 
donor-dependent variability in HC clearance rates in the 3D microbioreactor platforms is 
acceptably low. 
 
Effect of lipopolysaccharides (LPS) on HC clearance rate 
 Lipopolysaccharide is a component of Gram-negative bacterial cell walls and is 
associated with tissue injury and sepsis. To further unravel the mechanisms underlying 
inflammatory reactions in the liver, hepatocytes were plated in duplicate as cocultures with 
Kupffer cells at a 10:1 ratio and the media changed on day 4 to fresh media containing 
100nM HC with LPS at concentrations of 0, 0.1 and 1µg/mL. Culture media samples were 
collected at 0, 24, and 48 h. The media was then replaced on day 6 with fresh media 
containing 100nM HC and LPS and samples taken to day 8. For technical variation 
assessment, each replicate was extracted twice and each of the two extracts was run in 
positive ion mode in the RP-UHPLC-QTOF-MS two times consecutively.  HC 
concentrations in the bioreactor were plotted vs time (Supplemental Figure 10).  The rates 
are equivalent in every case when comparing non-inflamed cocultures with LPS-induced, 
suggesting that inflammation neither inhibited nor induced the activity of reductases 
involved in the metabolism of hydrocortisone in the bioreactors. The HC clearance rates 
from day 5 to 7 were similar to those from day 3 to day 5, indicating that extended exposure 
to LPS did not affect clearance (data not shown). 
  
Hydrocortisone metabolism: phase I/II metabolites 
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High accuracy exact mass, retention time, and database searching, followed by 
manual interpretation of collision induced dissociation (CID) MS/MS spectra, were used to 
confirm the structures of the hydrocortisone metabolites. The MS/MS spectra revealed a 
characteristic fragmentation pattern with ions at m/z 267.1747, 121.0650 and 163.1119. For 
example, the MS/MS spectrum of cortisone, which is the oxidized product of 
hydrocortisone, showed the m/z 163.1119 fragment as the most intense and characteristic 
ion, which is not found in the MS/MS spectrum of hydrocortisone (Supplemental Figure 
11).  As noted above (Fig. 6), approximately 70% of the hydrocortisone disappeared over 48 
h, and this was largely accounted for as 8% phase I metabolites, and 52 % as phase II 
metabolites.  In the absence of authentic standards, tetrahydrocortisone, and dihydrocortisol 
(phase I; Fig. 7) and tetrahydrocortisol, and tetrahydrocortisone glucuronides (phase II; Fig. 
8), were confirmed by comparing their retention times, exact monoisotopic masses, and 
MS/MS spectra with those of known hydrocortisone metabolites found in human urine. 
(Supplemental Figures 12 and 13).   
 
Hydrocortisone pharmacokinetics  
The pharmacokinetics of hydrocortisone was investigated after administration of 100 
nM HC to a coculture of human hepatocytes and Kupffer cells in the bioreactor. The HC 
concentrations in culture media were measured by LC–MS/MS and the pharmacokinetics 
were determined using standard pharmacokinetic equations (Eq. 1-4). 
The mean culture media concentration-time curve after administration of 100 nM 
hydrocortisone is shown in Fig. 6.  The half-life (t1/2), rate of elimination (kel), 
This article has not been copyedited and formatted. The final version may differ from this version.
DMD Fast Forward. Published on April 29, 2015 as DOI: 10.1124/dmd.115.063495
 at A
SPET Journals on M
ay 4, 2015
dm
d.aspetjournals.org
D
ow
nloaded from
 
DMD #63495 
 
 20
hydrocortisone clearance (CL) and the area under the curve (AUC) were estimated to be 
23.03 h, 0.03 h1, 6.6x10-5 L. h-1 and 1.03  

  h respectively (See also Table 1).  
Albumin is the most abundant plasma protein, with a half-life of three weeks (Peters, 
1970). Some drug molecules are rapidly excreted from the circulation, resulting in lower 
therapeutic efficacies.  In this regard, albumin plays a role in increasing plasma half-life 
through non-covalent interaction with the small molecules (Sleep et al., 2013).  Protein-drug 
binding may affect pharmacokinetic behaviors, including the half-life of a drug (Tayman et 
al., 2011).  It is interesting to see whether protein concentration may show the similar effect 
in the 3D microbioreactors.  To test this hypothesis, we used higher concentration of human 
serum albumin (25 mg/mL) and analyzed the HC clearance. The half-life calculated for high 
protein concentration was higher in comparison to 1.25 mg/mL HSA (t1/2 = 34.36 h vs t1/2 = 
23.03 h), indicating that the number of available interactions with the HC extended the half-
life.  Hydrocortisone was 50% bound with 25 mg/L albumin, and almost all free with 1.25 
mg/mL albumin.  The fraction unbound (fu) was expressed using Eq. 5, where [D] is the free 
drug concentration and [DP] is the concentration of drug protein complex.  
 


  




 
            (Eq. 5) 
 
Extrapolation of in vivo intrinsic clearance (CLint in vivo ) of hydrocortisone from in 
vitro data  
The prediction of human clearance is a key objective in drug discovery.  It is 
therefore important to establish an in vitro/in vivo correlation (IVIVC) for the clearance of 
hydrocortisone based on in vitro metabolism data.  For this, in vitro data from the 3D 
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microbioreactor was used to estimate expected in vivo data that could be compared with the 
in vivo clearance in humans.  The in vitro half-life was used to calculate the in vitro intrinsic 
clearance using the scaling factors in Eq. 6: 
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Scaling parameters were used for the calculations (Supplemental Table 3) (Davies 
and Morris, 1993; Obach et al., 1997). The hepatic clearance (CLh) was calculated from 
CLint using the well-stirred model (Eq. 7) (Pang and Rowland, 1977a; Pang and Rowland, 
1977b).  CLh was calculated for hydrocortisone, correcting for the plasma protein binding (fu 
b) from the literature (Robin et al., 1978), and using Eq. 7 where Q is the hepatic blood flow 
rate and fu inc is the unbound fraction in hepatocytes from the bioreactor. To compare in vivo 
intrinsic clearance values with in vitro in vivo clearance values, Eq. 7 was rearranged into 
Eq. 8 (Davies and Morris, 1993; Bayliss et al., 1999; Chiba et al., 2009; Chan et al., 2013). 
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The intrinsic clearance (CLint) calculated by equation 6 was 5.7 mL/min/kg, and the 
hepatic clearance was 1.1 mL/min/kg (assuming fu = 1). The in vivo clearance data from 
LiverChip calculated in mL/min/kg was converted to L/h using the human body weight 
(average body weight = 70 kg). The CLint - in vivo was calculated to be 23.8 L/h, which is 1.3 
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fold higher than human in vivo clearance, i.e., approximately 18 L/h (Derendorf et al., 
1991). 
 
DISCUSSION 
Multiple approaches aimed at halting the relatively rapid de-differentiation of 
primary hepatocytes in monolayer in vitro cultures have been studied.  Co-culturing of 
hepatocytes with feeder or liver non-parenchymal cells (NPCs) has proved effective, as has 
3D culture in various formats, including bioreactors. Work in this area typically focuses on 
maintenance of hepatic viability and function with relatively less emphasis placed on 
deploying the models to explore disease states such as inflammation or in concert with high 
quality analytics to produce detailed pharmacokinetic information. A notable exception is 
the micropattern cocultures first published by Khetani and Bhatia (Khetani and Bhatia, 
2006; Khetani and Bhatia, 2008), which have been used for extensive clearance and 
metabolite identification studies (Wang et al., 2010; Dash et al., 2012; Chan et al., 2013). 
Here we demonstrate an inflammatory liver model supported in a 3D bioreactor culture 
system to explore the metabolism and anti-inflammatory effects of hydrocortisone.  
We developed 3D cultures of primary hepatocytes and a mixed fraction of liver 
NPCs as unsupported spheroids and in scaffold-containing bioreactors have been shown to 
maintain hepatic viability and produce pro-inflammatory cytokines on stimulation with high 
concentrations of LPS (Dash et al., 2009a; Messner et al., 2013). The NPCs in these models 
likely play a dual role, both supporting hepatic function and through the incorporated 
Kupffer cells recapitulating inflammatory response.  In the model described here, a modular 
approach starting from separate stocks of cryopreserved human hepatocytes and Kupffer 
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cells, has been taken. The bioreactor and 3D scaffold are sufficient to maintain hepatocyte 
viability for extended periods in the presence or absence of NPC (Powers et al., 2002b; 
Sivaraman et al., 2005; Vivares et al., 2014).  Kupffer cells can therefore be added to the 
cultures in well-defined ratios, allowing the evaluation of models of non-inflamed, mild and 
highly inflamed livers with hepatocyte to Kupffer cells ratios ranging from 15:1 and 2.5:1. 
Glucocorticoids are necessary in the media of primary hepatocyte cultures, as they 
assist in the preservation of the differentiated state as reflected, e.g., by the maintenance of 
CYP450 levels (Schuetz and Guzelian, 1984; Schuetz et al., 1984).  In the media for Kupffer 
cell monocultures, glucocorticoids are removed or kept at low nanomolar concentrations as 
their presence blunts cytokine production.  Hydrocortisone, or cortisol, is the major human 
glucocorticoid; here we confirm that hepatocyte and Kupffer cell cocultures can be 
maintained in hydrocortisone-containing media and that hydrocortisone shows a dose 
dependent anti-inflammatory effect. When compared to hydrocortisone at 100 nM, 
dexamethasone has a more potent anti-inflammatory effect as judged by suppression of 
cytokine production, reflecting the situation in vivo. 
The metabolism of hydrocortisone has not been extensively investigated in vitro in 
3D perfusion models, particularly at concentrations near physiological free levels. To 
exemplify the utility of the model not only for anti-inflammatory drug testing but also for 
complex drug metabolism studies, a detailed characterization of hydrocortisone 
disappearance and metabolite profile has been undertaken.   For metabolism studies of 
hydrocortisone, an initial concentration of 100 nM was used.  The hydrocortisone was 
depleted to 30 nM after 48 h, with first order kinetics.  LC-MS approaches were used to 
identify the metabolites produced in the bioreactor; tetrahydrocortisone and 
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dihydrocortisone were identified as major and minor phase I metabolites, respectively.  The 
majority of the metabolism, however, was glucuronidation; phase II metabolites were 
identified as tetrahydrocortisol glucuronide and tetrahydrocortisone glucuronides. Towards 
the end of the application period the formation rates of tetrahydrocortisol glucuronide and 
tetrahydrocortisone glucuronide were higher than at earlier time points in the bioreactor 
cultures, suggesting that UDP-glucuronosyltransferase(Kaji and Kume, 2005) and other 
oxodoreductases (reductive enzymes), were present in the bioreactor cultures.   
Donor-to-donor variability was assessed by comparing the HC disappearance rates 
of several donors. The donor-dependent variability is low, supporting the promise of this 
microphysiological system as a tool for investigating drug metabolism and anti-
inflammatory effects (Supplemental Figure 9).  
To address whether the hydrocortisone nominal disappearance included a 
contribution from prior or metabolically-formed cortisone, we used [9,11,12,12-2H4] 
hydrocortisone (d4-hydrocortisone) as a tracer (Supplemental Figure 14).  The deuterated 
isotopomer can be distinguished from unlabeled hydrocortisone by the mass difference of 4 
Da.  Metabolism by the 11β-HSD type 2 enzyme would yield cortisone, with the deuterium 
at the 11β position being lost.  The resulting [9,12,12-2H3] cortisone (d3-cortisone) would 
have a mass 1 Da less than that of the d4-hydrocortisone. Subsequent conversion of 
cortisone via 11β-HSD type1 back to hydrocortisone would yield d3-hydrocortisone, which 
is 1 Da less than the starting isotopomers.  Regeneration of d4-hydrocortisone is unlikely 
since this would require re-introduction of highly-diluted deuterium at the 11β position.  
The 1-dalton mass difference, and the contribution of the 13C abundance of the d4 
compound to the signal from the presumed d3-hydrocortisone, preclude a detailed 
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interpretation.  There appears, however, to be some cortisone-hydrocortisone inter-
conversion, although the net effect on hydrocortisone disappearance is modest at best. 
To further understand the functionality of the Kupffer cells in cocultures with 
hepatocytes, the system was exposed to LPS for 48 h to stimulate inflammation.  The 
disappearance rate of hydrocortisone was not affected by stimulation of the cultures with 
LPS. We have demonstrated that hydrocortisone is primarily metabolized by phase II 
enzymes and hypothesize that this is the reason that LPS stimulation has little effect on 
clearance rate.  LPS stimulation causes the release of pro-inflammatory cytokines which are 
known to down regulate CYP450 (Milosevic et al., 1999).  
Pharmacokinetic parameters were estimated for the in vitro metabolism and to 
establish IVIVC of hydrocortisone behavior.  The intrinsic clearance (CLint) was ~5.7 
mL/min/kg (calculated by using Eq. 6). Hepatic clearance was ~1.1 mL/min/kg (assuming fu 
= 1), and the calculated value for CLint - in vivo was 23.8 L/h, which is 1.3 times that of human 
in vivo clearance, (approximately 18 L/h (Derendorf et al., 1991)).  The intrinsic clearance 
values and the metabolites generated in the perfused human 3D microbioreactor correlated 
generally with human data.   
In summary, CYP activities, total protein, albumin and urea levels were maintained 
for extended periods of coculture in the microphysiological system, a useful tool for 
pharmacological or toxicological investigations requiring a highly stable and reproducible 
physiological in vitro representation of the human liver.  
We demonstrated the applicability of a recently developed bioreactor for long-term 
pharmacological investigations on human hepatocytes coculture system, using 
hydrocortisone as a steroidal anti-inflammatory drug model. Correlations between in vitro 
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and in vivo data (IVIVC) were generated, suggesting that 3D microphysiological systems 
with mixed human cell populations could be used as tools for investigating drug metabolism 
and toxicity for drug development. 
Overall, the biology in the coculture system and the in vitro and in vivo hepatic 
clearance correlation data suggest that the roles of various uptake and efflux transporters in 
drug efficacy and toxicity studies in these systems may also correlate with the human liver 
in vivo.  
Thus, especially if interactions with non-parenchymal cells are involved, the 
miniaturized bioreactor may be a useful model system to increase predictivity in 
pharmacological and toxicological studies on a sub-chronic timescale. In addition, the 
culture system facilitates histological analyses of pharmacology-related structural 
characteristics of human liver tissue. 
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LEGENDS FOR FIGURES 
 
Fig. 1: Difussion of cortisol to the nucleus. Cortisol is the most common glucocorticoid 
and is essential for life. It supports and regulates cardiovascular, metabolic, immunologic, 
and homeostatic functions. 
 
Fig. 2: Microfluidic 3D tissue culture system. A) LiverChip: This device is a multiwell 
plate platform that enables maintenance of 3D liver tissue cultures under perfusion, B) 
LiverChip hardware, C) Scaffold containing 301 channels in which cells are seeded. 
Typically 0.6 x 106 human hepatocytes can be seeded per scaffold, D) Schematic of flow 
through a single LiverChip culture well.  
 
Fig. 3:  Tissue formation in cocultures plated at different cell type ratios. Phase contrast 
imaging (Nikon, Ti-Eclipse) was used to assess the morphology of the tissue formation after 
7 days in culture. A) Monoculture, B) Coculture 10:1.  
 
Fig. 4: Inflammation stimulated by the addition of 1 µg/mL LPS to the mono-culture 
and coculture systems seeded at 2.5:1, 10:1 and 15:1 ratios. TNFα was measured as a 
marker of Kupffer cell activation. n=3 replicates, single donor. Results are reported as mean 
± SD. 
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Fig. 5: Experimental workflow used for the quantification of hydrocortisone as 
metabolite profiling.  The method consists of spiking with internal standard, liquid 
extraction and mass spectrometry analysis. 
 
Fig. 6: Hydrocortisone disappearance over time. n=2 for biological and technical 
replicates. Lines represent mean ± SD. 
 
Fig. 7: Phase I metabolites. 8-10% of hydrocortisone was found as phase I metabolites 
including tetrahydrocortisone and dihydrocortisol.    
 
Fig. 8: Phase II metabolites. 45-52 % of hydrocortisone was found as phase II metabolites 
including tetrahydrocortisol glucuronide and tetrahydrocortisone glucuronide. 
 
 
 
 
 
 
 
 
 
 
 
This article has not been copyedited and formatted. The final version may differ from this version.
DMD Fast Forward. Published on April 29, 2015 as DOI: 10.1124/dmd.115.063495
 at A
SPET Journals on M
ay 4, 2015
dm
d.aspetjournals.org
D
ow
nloaded from
 
DMD #63495 
 
 42
TABLE 
 
Symbol Characteristic Value Unit 
t1/2 Elimination half-life 23 h 
kel Elimination rate constant 0.03 h-1 
Vd Volume of distribution 2.2 mL 
CL Clearance 6.6x10-5 L.h-1 
AUC Area under the curve 1.03 
 
  ! 
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